ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,964Medicare Part D Prescriptions Filled, Including Refills

Rank: 290 out of 944

$443K Total Retail Price of All Prescriptions

Rank: 275 out of 944

288 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 288 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 288 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 6,372 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 472 408 1 2
LISINOPRIL 306 255 2 3
AMLODIPINE BESYLATE 260 219 3 5
OMEPRAZOLE 219 172 4 4
HYDROCODONE-ACETAMINOPHEN 196 154 S3 5 10
SIMVASTATIN 194 150 6 1
FUROSEMIDE 192 170 7 6
PRAVASTATIN SODIUM 165 135 8 17
METFORMIN HCL 163 148 9 12
ZOLPIDEM TARTRATE 154 126 10 25
GABAPENTIN 152 108 11 18
POTASSIUM CHLORIDE 150 136 12 15
SERTRALINE HCL 134 121 13 23
DONEPEZIL HCL 105 105 14 24
LOSARTAN POTASSIUM 103 88 15 16
ALENDRONATE SODIUM 95 93 16 20
MIRTAZAPINE 92 88 17 35
ALLOPURINOL 91 87 18 22
ATORVASTATIN CALCIUM 90 80 19 13
CARVEDILOL 87 59 20 30
PREDNISONE 85 70 21 32
WARFARIN SODIUM 84 70 22 7
PANTOPRAZOLE SODIUM 84 79 22 34
METOPROLOL TARTRATE 80 69 24 8
ADVAIR DISKUS 78 65 25 31
LANTUS SOLOSTAR 77 35 26 61
TRIAMTERENE-HCTZ 75 70 27 33
ATENOLOL 73 73 28 11
METOPROLOL SUCCINATE 72 72 29 14
POLYETHYLENE GLYCOL 3350 72 67 29 41
TRAZODONE HCL 69 34 31 45
CLONIDINE HCL 68 53 32 67
SYNTHROID 63 52 33 82
NOVOLOG FLEXPEN 63 37 33 169
NAMENDA 63 63 33 37
SPIRONOLACTONE 62 53 36 44
TRAMADOL HCL 61 52 37 21
FLUTICASONE PROPIONATE 61 51 37 40
LIDODERM 59 51 39 73
LOVASTATIN 55 54 40 26
DOXAZOSIN MESYLATE 53 47 41 60
KLOR-CON M10 53 53 41 122
CYCLOBENZAPRINE HCL 53 15 R 41 86
OXYCONTIN 52 39 S2 44 92
VENLAFAXINE HCL ER 52 30 44 84
CITALOPRAM HBR 51 32 46 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.